

I2Cure Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.05 Cr
- Revenue Growth 270.58%
- Profit Growth 137.72%
- Ebitda 134.18%
- Net Worth 38.36%
- Total Assets 285.32%
About I2Cure
I2cure Private Limited (IPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 June 2020 (Four years and ten months 5 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.05 Cr.
Somenath Ghosh and Drishti Dadu serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290DL2020PTC365048
- Company No.
365048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does I2cure Private Limited offer?
I2Cure Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Common Disease Medicines, Oral Care Products.
Who are the key members and board of directors at I2Cure?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Somenath Ghosh ![]() | Additional Director | 23-Jan-2024 | Current |
Drishti Dadu ![]() | Additional Director | 30-Aug-2024 | Current |
Financial Performance of I2Cure.
I2Cure Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 270.58% increase. The company also saw a substantial improvement in profitability, with a 137.72% increase in profit. The company's net worth Soared by an impressive increase of 38.36%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of I2Cure?
In 2022, I2Cure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Team Indus Foundation For Excellence
Somenath Ghosh is a mutual person
- I2 Private Limited
Drishti Dadu is a mutual person
- Sudrish Consumer Products Private Limited
Drishti Dadu is a mutual person
Charges (Loans)
₹40.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
06 May 2022 | Others | ₹4.00 Cr | Open |
20 Jun 2021 | Others | ₹0.50 M | Open |
How Many Employees Work at I2Cure?
I2Cure has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of I2Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I2Cure's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on I2Cure
Recent activity within the organization
- Director Appointment
Drishti Dadu was appointed as a Additional Director was appointed as a Additional Director on 30 Aug 2024 & has been associated with this company since 7 months 25 days .
- Director Appointment
Somenath Ghosh was appointed as a Additional Director was appointed as a Additional Director on 23 Jan 2024 & has been associated with this company since 1 year 3 months .
- Annual General Meeting
I2Cure Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 40.00 M with Charge ID 100580798 was registered on 06 May 2022.
- Balance Sheet
I2Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 0.50 M with Charge ID 100457836 was registered on 20 Jun 2021.
Frequently asked questions
What is the Incorporation or founding date of I2Cure Private Limited?
I2Cure Private Limited was incorporated on 19 Jun 2020.
What is authorized share capital and paid-up capital of I2Cure Private Limited?
The authorized share capital of I2Cure Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of I2Cure Private Limited?
Currently 2 directors are associated with I2Cure Private Limited.
- Somenath Ghosh
- Drishti Dadu
What is the registered address of I2Cure Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of I2Cure Private Limited is 147, M.G. Road New Manglapuri India, New Delhi, 110030.
What is the corporate identification number (CIN) and company number of I2Cure Private Limited?
The corporate identification number (CIN) of I2Cure Private Limited is U24290DL2020PTC365048 and the company number is 365048 as per Ministry of Corporate Affairs (MCA).
What is the official website of I2Cure Private Limited?
The Official website of I2Cure Private Limited is https://www.i2cure.com
What has been the recent revenue trend for I2Cure Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for I2Cure Private Limited has risen by 270.58%.
What change has been observed in the net worth of I2Cure Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of I2Cure Private Limited has experienced an upsurge of 38.36%.
What are the total open charges for I2Cure Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for I2Cure Private Limited amount to ₹ 4.05 Cr.
When was the last Balance Sheet of I2Cure Private Limited filed with the ROC?
The most recent Balance Sheet for I2Cure Private Limited was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Ramesh MenonAdditional Director
AK
Anil KejriwalDirectorRK
Ritwik KejriwalDirectorRK
Ruppa KejriwalDirectorSP
Sanjib PalAdditional Director
Similar Companies Based on Biotechnology
- Venkateshwara B.V. Biocorp Private Limited Pune, Maharashtra, India
- Sanofi Healthcare India Private Limited Mumbai, Maharashtra, India
- Biotechnology Industry Research Assistance Council Delhi, India
- Invitrogen Bioservices India Private Limited Bangaluru, Karnataka, India
- Ecso Global Private Limited New Delhi, India
- Gennova Biopharmaceuticals Limited Pune, Maharashtra, India
- Aurigene Oncology Limited Bangaluru, Karnataka, India